Breaking News Headlines Today

News about Biotech

Stay current with all the latest and breaking news about Biotech, compare headlines and perspectives between news sources on stories happening today. In total, 119 stories have been published about Biotech which Ground News has aggregated in the past 3 months.

Covered Most By

stocktitan.net

Unknown

DirectorsTalk Interviews

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring A Potential 116% Upside In Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is making waves within the healthcare industry. The company, based in Hampton, New Jersey, is dedicated to the development of therapeutic antibodies, aiming to address severe inflammatory, allergic, autoimmune, and other diseases. With a current market capitalization of $1.64 billion, Celldex is positioned at the forefront of biotech innovation, focusing o…Biotech · New Jersey Read Article

Woman Receives First Face Transplant from Euthanized Donor

44% Right coverage: 32 sources

Abivax or the Success of a French Biotech Courted by the Big Labs

100% Left coverage: 1 sources

Two major foreign pharmaceutical laboratories are said to have positioned themselves to buy the small French company, which specializes in chronic inflammatory bowel diseases.Biotech · Paris Read Article

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

100% Right coverage: 1 sources

ASPI’s Paul Mann accelerates a bold global isotope strategy, linking helium supply with medical isotope demand.Biotech · Australia Read Article

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Canadian bioinformatics is responsible for one of the technology companies that has set out to open the melon of the edition of human embryos, which transcends ethical boundaries and is of serious concern to the scientific community. For bioethics specialists, Cathy Tie is a nightmare disguised as “Technological Barbie.” This nickname was given by Nature magazine after she herself recorded a video taking the role of Mattel’s wrist to replicate t…Biotech · Canada Read Article

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

100% Left coverage: 1 sources

Canadian bioinformatics is responsible for one of the technology companies that has set out to open the melon of the edition of human embryos, which goes beyond ethical limits and seriously worries the scientific community Hemeroteca - The genetic ‘Manhattan project’: several companies want to modify embryos and open the way to ‘babies a la carte’ For bioethics specialists, Cathy Tie is a nightmare disguised as “Technological Barbie.” This nickn…Biotech · Spain Read Article

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech With Nearly 95% Upside Potential

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company specializing in central nervous system (CNS) disorders, is garnering significant attention in the investment community. With a market capitalization of $1.27 billion, this Boston-based company is focused on the discovery and development of innovative small molecule medicines, making it a compelling speculative play in the biotechnology sector. The company’s fla…Biotech · Boston Read Article

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch

100% Left coverage: 1 sources

Key PointsCRISPR Therapeutics is targeting multiple difficult-to-treat diseases with several candidates. The company's shares could soar if it delivers consistent clinical and regulatory progress.However, the stock is somewhat risky as the business is mostly in its clinical stages.10 stocks we like better than CRISPR Therapeutics › Artificial intelligence (AI) is slowly changing and reshaping industries, from banking to telecom. The technology w…Artificial Intelligence · United States Read Article

News about Biotech

News about Biotech

Covered Most By

Local News Publishers

Top Biotech News

UAE and Colossal Biosciences to Build Genetic 'Noah's Ark' in Dubai

Woman Receives First Face Transplant from Euthanized Donor

Study: Engineered Algae Can Remove 91% of Microplastics in One Hour

UAE and Colossal Biosciences to Build Genetic 'Noah's Ark' in Dubai

Study: Engineered Algae Can Remove 91% of Microplastics in One Hour

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring A Potential 116% Upside In Biotech Innovation

Woman Receives First Face Transplant from Euthanized Donor

Abivax or the Success of a French Biotech Courted by the Big Labs

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech With Nearly 95% Upside Potential

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Biotech

UAE and Colossal Biosciences to Build Genetic 'Noah's Ark' in Dubai

Study: Engineered Algae Can Remove 91% of Microplastics in One Hour

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring A Potential 116% Upside In Biotech Innovation

Woman Receives First Face Transplant from Euthanized Donor

Abivax or the Success of a French Biotech Courted by the Big Labs

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech With Nearly 95% Upside Potential

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch

News about Biotech

News about Biotech

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Biotech News

UAE and Colossal Biosciences to Build Genetic 'Noah's Ark' in Dubai

Woman Receives First Face Transplant from Euthanized Donor

Study: Engineered Algae Can Remove 91% of Microplastics in One Hour

UAE and Colossal Biosciences to Build Genetic 'Noah's Ark' in Dubai

Study: Engineered Algae Can Remove 91% of Microplastics in One Hour

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring A Potential 116% Upside In Biotech Innovation

Woman Receives First Face Transplant from Euthanized Donor

Abivax or the Success of a French Biotech Courted by the Big Labs

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech With Nearly 95% Upside Potential

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Biotech

UAE and Colossal Biosciences to Build Genetic 'Noah's Ark' in Dubai

Study: Engineered Algae Can Remove 91% of Microplastics in One Hour

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring A Potential 116% Upside In Biotech Innovation

Woman Receives First Face Transplant from Euthanized Donor

Abivax or the Success of a French Biotech Courted by the Big Labs

Paul Mann’s relentless deal machine: After swallowing Renergen, ASPI bets big on Biotech

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Cathy Tie, Biotech: “in Ten Years, Editing Human Embryos Will Be as Normal as in Vitro Fertilization”

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech With Nearly 95% Upside Potential

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch

Local News Publishers